Dermatology · Danbury, CT
NPI
1164719043
Since 2011
Specialty
Dermatology
Code 207N00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
25 Tamarack Ave
Danbury, CT, 06811
Phone (203) 797-8990
Groups this clinician bills Medicare through
Medicare paid, 2024
$98K
1,722 services
Medicare patients, 2024
403
Average age 75
Drug cost, 2024
$2.3M
2,134 prescriptions
Company payments, 2025
$1,165
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marimeg Q Clairwood was code 17003 (destruction skin lesion), 373 times for 94 patients. In total Marimeg Q Clairwood billed 1,722 services in 41 codes, and Medicare paid $98K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 373 | 94 | $5.75 | $2,145 |
| 99213 Office E&M - Established | Office | 312 | 244 | $70.18 | $22K |
| 11102 Skin Biopsy | Office | 185 | 163 | $82.10 | $15K |
| 99214 Office E&M - Established | Office | 173 | 128 | $104.44 | $18K |
| 17000 Destruction Skin Lesion | Office | 171 | 131 | $46.01 | $7,868 |
| 17110 Destruction Skin Lesion | Office | 54 | 40 | $97.76 | $5,279 |
| 11103 Skin Biopsy | Office | 54 | 46 | $42.19 | $2,278 |
| 99203 Office E&M - New | Office | 43 | 43 | $89.18 | $3,835 |
| 99204 Office E&M - New | Office | 28 | 28 | $136.07 | $3,810 |
| 99212 Office E&M - Established | Office | 27 | 25 | $40.87 | $1,104 |
| 11104 Skin Biopsy | Office | 26 | 24 | $102.93 | $2,676 |
| 12032 Wound Repair - All Levels | Office | 19 | 19 | $263.30 | $5,003 |
| 11602 Skin Lesion Excision | Office | 12 | 12 | $109.52 | $1,314 |
By year: 2022 $98K for 1,533 services; 2023 $99K for 1,684 services; 2024 $98K for 1,722 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marimeg Q Clairwood prescribed most often to Medicare patients was Ketoconazole, with 308 prescriptions and refills. In total Marimeg Q Clairwood wrote 2,134 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 308 | 335 | 139 | $4,142 |
| Triamcinolone Acetonide Generic | 116 | 121 | 89 | $860 |
| Mupirocin Generic | 103 | 103 | 90 | $778 |
| Dupixent Pen Dupilumab | 100 | 101 | Under 11 | $426K |
| Ciclopirox Generic | 93 | 101 | 33 | $2,378 |
| Hydrocortisone Generic | 86 | 87 | 73 | $596 |
| Tretinoin Generic | 64 | 67 | 21 | $3,996 |
| Minoxidil Generic | 61 | 174 | 16 | $602 |
| Clindamycin Phosphate Generic | 60 | 61 | 31 | $1,648 |
| Tacrolimus Generic | 59 | 59 | 31 | $9,115 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 59 | 62 | 33 | $1,580 |
| Mometasone Furoate Generic | 59 | 61 | 51 | $713 |
| Clobetasol Propionate Generic | 58 | 60 | 40 | $2,804 |
| Fluorouracil Generic | 49 | 52 | 48 | $3,455 |
| Dupixent Syringe Dupilumab | 46 | 46 | Under 11 | $191K |
Brand drugs: 423 claims; generic drugs: 1,711 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marimeg Q Clairwood $1,165 ($1,165 in general payments such as food, travel and fees) from 18 companies. The largest payer was Pfizer Inc. with $174.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 5 | $174 |
| UCB, Inc. UCB.BR | 4 | $163 |
| Janssen Biotech, Inc. JNJ | 5 | $115 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 4 | $92.81 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 4 | $87.06 |
| Galderma Laboratories, L.P. GALD.SW | 5 | $83.9 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $79.99 |
| Abbvie Inc. ABBV | 2 | $55.85 |
| Amgen Inc. AMGN | 2 | $52.19 |
| Genzyme Corporation SNY | 2 | $44.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.